Clinical Pharmacology & Therap Philadelphia, PA - 19103

Clinical Pharmacology & Therap is categorized under Periodical Publishers in Philadelphia, PA .

Clinical Pharmacology & Therap was established in 0, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Periodical Publishers business, which does work in the B2B market, and is classified as a Periodical Publishers, under code number 5111200 by the NAICS.

If you are seeking more information, feel free to contact at the company’s single location by writing to 1600 John F Kennedy Boulevard # 1800, Philadelphia, Pennsylvania PA 19103 or by phoning (215) 239-3714. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Clinical Pharmacology & Therap
Address: 1600 John F Kennedy Boulevard # 1800, Philadelphia, Pennsylvania 19103
Phone Number: (215) 239-3714
Website Address: elsevier.com
Annual Revenue (USD): $2.500.000 to $4.999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Periodical Publishers
SIC Code: 2721
NAICS Code: 5111200
Share This Business:

Clinical Pharmacology & Therap was started in 0 to provide professional Periodical Publishers under the SIC code 2721 and NAICS code 5111200. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact for inquiries that concern Clinical Pharmacology & Therap by calling the company number (215) 239-3714, as your correspondence is most welcome. Additionally, the physical location of the single location of Clinical Pharmacology & Therap can be found at the coordinates 39.953751,-75.166673 as well as the street address 1600 John F Kennedy Boulevard # 1800 in Philadelphia, Pennsylvania 19103.

For its online presence, you may visit Clinical Pharmacology & Therap’s website at elsevier.com and engage with its social media outlets through on Twitter and on Facebook.